中醫(yī)藥學(xué)循證醫(yī)學(xué)文獻(xiàn)閱讀-文庫吧資料
2025-01-06 13:02本頁面
【正文】 cts and data Cognition shows benefit for Ginkgo (dose less than 200mg/day) pared with placebo at 12 weeks (SMD , 95% CI , , P=, random effects model). 掌握 7. same pattern with different subjects and data Activities shows benefit for Ginkgo (dose less than 200mg/day) pared with placebo at 12 weeks (SMD , 95% CI , , P=, random effects model). 掌握 7. same pattern with different subjects and data Measures of mood… shows benefit for Ginkgo (dose less than 200mg/day) pared with placebo at 12 weeks (SMD , 95% CI , , P=, random effects model). 掌握 53 當(dāng)代 (科技 )醫(yī)學(xué)英語特點 8. Reviewers? conclusions ① Merits ② Imperfect ③ Prospect 掌握 8. Reviewers? conclusions – 優(yōu)點 Ginkgo biloba appears to be safe in use with no excess side effects pared with placebo. 應(yīng)用白果相對安慰劑 無 過度副作用， 顯得 (似乎 )安全。 掌握 7. Main results – 先總 meta There are benefits (主語 ) associated with Ginkgo (dose less than 200mg/day) pared with placebo at less than 12 weeks (54/63 showed improvement pared with 20/63, OR , 95% CI to , P=). 掌握 7. Results – 統(tǒng)計判斷 掌握 a/b 效應(yīng)概率 陽性數(shù) /總數(shù) 54/63 OR(優(yōu)勢比 ) 陽性概率 /陰性概率 小樣本 數(shù)越大，優(yōu)勢比大 大樣本 數(shù)字小，優(yōu)勢比也大 95% CI(可信區(qū)間 ) 無零，數(shù)字大，顯著 。 6. collection analysis meta Data for the metaanalyses are based on reported summary statistics for each study. 供薈粹分析分析的資料取自每個研究的發(fā)表總結(jié)性統(tǒng)計。 掌握 4. Search strategy – 3T Time Types Terms 4. Strategy – Time Types Trial were identified on 26 June 2023 through a search of the CDCIG…… 39 synonym 同義詞 asterisk * The search terms used were ginkgo*, tanakan, EGB761, EGB761 and EGB 761. 所用檢索術(shù)語為 ginkgo*、 tanakan、 EGB76 EGB761與 “EGB 761”。 掌握 2. Background – status② A standardized extract is widely prescribed in Germany and France for the treatment of a range of conditions
教學(xué)課件相關(guān)推薦
鄂ICP備17016276號-1